财报披露
Evogene(EVGN)01-19 20:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000202 Act: 34 Size: 40 KB 网页链接
Biomica是一家临床阶段的创新药企业,通过高分辨率的计算平台进行微生物基因组学分析,合理设计微生物菌株组合,进而研发配方菌创新药物。母公司Evogene(Nasda...
Evogene(EVGN)01-19 20:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000202 Act: 34 Size: 40 KB 网页链接
Evogene(EVGN)01-13 05:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000162 Act: 34 Size: 10 KB 网页链接
Evogene(EVGN)2022-12-22 14:29
本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接
Evogene(EVGN)2022-12-21 19:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004393 Act: 34 Size: 376 KB 网页链接
Evogene(EVGN)2022-11-17 20:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004079 Act: 34 Size: 504 KB 网页链接
Evogene(EVGN)2022-11-10 20:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003910 Act: 34 Size: 11 KB 网页链接
Evogene(EVGN)2022-11-14 20:21
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003978 Act: 34 Size: 4 MB 网页链接
Evogene(EVGN)2022-11-04 04:36
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003805 Act: 34 Size: 27 KB 网页链接
Evogene(EVGN)2022-10-12 18:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003628 Act: 34 Size: 34 KB 网页链接
Evogene(EVGN)01-19 20:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000202 Act: 34 Size: 40 KB 网页链接查看全文
Evogene(EVGN)01-13 05:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000162 Act: 34 Size: 10 KB 网页链接查看全文
Evogene(EVGN)2022-12-22 14:29
本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接查看全文
动脉网2022-12-22 08:29
动脉网获悉,以色列创新药初创企业Biomica近日宣布完成新一轮融资,本轮融资由上海生物医药基金与Biomica母公司Evogene联合投资。
Biomica是一家临床阶段的创新药企业,通过高分辨率的计算平台进行微生物基因组学分析,合理设计微生物菌株组合,进而研发配方菌创新药物。母公司Evogene(Nasda...查看全文
Evogene(EVGN)2022-12-21 19:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004393 Act: 34 Size: 376 KB 网页链接查看全文
Evogene(EVGN)2022-11-17 20:06
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004079 Act: 34 Size: 504 KB 网页链接查看全文
Evogene(EVGN)2022-11-14 20:21
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003978 Act: 34 Size: 4 MB 网页链接查看全文
Evogene(EVGN)2022-11-10 20:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003910 Act: 34 Size: 11 KB 网页链接查看全文
Evogene(EVGN)2022-11-04 04:36
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003805 Act: 34 Size: 27 KB 网页链接查看全文
Evogene(EVGN)2022-10-12 18:12
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003628 Act: 34 Size: 34 KB 网页链接查看全文
本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000202 Act: 34 Size: 40 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-23-000162 Act: 34 Size: 10 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004393 Act: 34 Size: 376 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004291 Act: 34 Size: 23 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-004079 Act: 34 Size: 504 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003978 Act: 34 Size: 4 MB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003910 Act: 34 Size: 11 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003805 Act: 34 Size: 27 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003628 Act: 34 Size: 34 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-003479 Act: 34 Size: 33 KB 网页链接